openPR Logo
Press release

Investigation announced for Investors in shares of Apyx Medical Corporation (NASDAQ: APYX)

04-28-2022 03:37 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations.

An investigation for investors in Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations.

An investigation was announced over potential securities laws violations by Apyx Medical Corporation in connection with certain financial statements.

Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Apyx Medical Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Clearwater FL based Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. Apyx Medical Corporation reported that its annual Total Revenue rose from $27.71 million in 2020 to $48.51 million in 2021, and that its Net Loss increased from $11.89 million in 2020 to $15.17 million in 2021.

On March 14, 2022, Apyx Medical Corporation disclosed that the U.S. Food and Drug Administration ("FDA") would be posting a Medical Device Safety Communication ("MDSC") related to the Company's Advanced Energy Products. The Company further disclosed that "[b]ased on our initial interactions with the FDA, we believe the Agency's MDSC will pertain to the use of our Advanced Energy products outside of their FDA-cleared indication for general use in cutting, coagulation, and ablation of soft tissue during open and laparoscopic surgical procedures."

Shares of Apyx Medical Corporation (NASDAQ: APYX) declined from $11.18 per share on March 1, 2022, to as low as $4.14 per share on April 27, 2022.

Those who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and should contact the Shareholders Foundation.

Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Apyx Medical Corporation (NASDAQ: APYX) here

News-ID: 2613170 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Medical

ECG Analysis System Market Research Report 2022 - GE Medical, Medical Econet, Gr …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global ECG Analysis System. On the basis of historic growth analysis and current scenario of ECG Analysis System place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent
ECG Analysis System Market Outlook: 2020 The Year On A Positive Note | GE Medica …
DataIntelo report titled Global ECG Analysis System Market provides detailed information and overview about the key influential factors required to make well informed business decision. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of
Medical Tracheostomy Tube Market Overall Study Report 2020-2027 | Players Medtro …
The latest report added by Stratagem Market Insights gives deep insights into the drivers and restraints in the Worldwide Medical Tracheostomy Tube Market. The research report "Global Medical Tracheostomy Tube Market Size and Growth Forecast to 2027" provide a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Medical Tracheostomy Tube market and the current trends that are likely to shape its future.
Global Embolization Particle Market 2019 - Sirtex Medical, Merit Medical, Cook M …
The global "Embolization Particle Market" report delivers a comprehensive and systematic framework of the Embolization Particle market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Embolization Particle market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis and calculations. The
Medical Casting & Splinting Market 2019: Top Key players are 3M, DJO Global, BSN …
Medical Casting & Splinting Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13718924 Global Medical Casting & Splinting market 2019 research provides a basic overview of
Global Oxygen Pressure Regulator Market 2017 : Precision Medical, Smiths Medical …
Oxygen Pressure Regulator A market study based on the " Oxygen Pressure Regulator Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Oxygen Pressure Regulator Market 2017’. The research report analyses the historical as well as present performance of the worldwide Oxygen Pressure Regulator industry, and makes predictions on the future status of Oxygen Pressure Regulator market on the basis of this analysis. Get Free